GENEVA, Feb. 23 -- CSPC MEGALITH BIOPHARMACEUTICAL CO., LTD. (519, Cangsheng Road, High-Tech Development ZoneShijiazhuang, Hebei 050027), 石药集团巨石生物制药有限公司 (中国河北省石家庄市高新区仓盛路519号) filed a patent application (PCT/CN2025/114888) for "COMBINATION OF ANTIBODY-DRUG CONJUGATE AND TYROSINE KINASE INHIBITOR" on Aug 15, 2025. With publication no. WO/2026/037393, the details related to the patent application was published on Feb 19, 2026.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which...